Delivery Order SPE2DB20D3303-SPE2DB25FA2YZ
- Not listed
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,368.92 for AYVAKIT 25 mg tablets (30-count packaging) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $21,917.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AYVAKIT 300 MG tablets. Under this order, Amerisourcebergen will deliver 30 tablets of AYVAKIT 300 MG to a location in Conshohocken, Pennsylvania by August 2, 2023 to support the Defense Logistics Agency's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen will utilize its established network to ensure troops and military families have access to...
- Amerisourcebergen Drug Corp has received a $43,822 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply AYVAKIT 200 MG TABLET 30S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to support DLA medical facilities by December 2023. The delivery order was awarded without a set-aside designation against an existing indefinite delivery contract held by Amerisourcebergen's Corporate Office division to...
- The Defense Logistics Agency awarded a delivery order valued at $43,835.58 to Amerisourcebergen Drug Corporation for the provision of 4561893625 AYVAKIT 300 MG TABLET 30S. The firm fixed price order is being carried out under the Prime Vendor Pharmaceutical program, with performance taking place in Conshohocken, Pennsylvania through September 11, 2023. No set aside designation or subcontractors are indicated. This order supports the Defense Logistics Agency's mission to provide pharmaceuticals...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of Activase 50 mg vials valued at $3,207.38. This non-set-aside, competitively awarded contract features firm fixed pricing and an ultimate completion date of August 6, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense, and is being performed at the...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $48,737.84 contract is for the delivery of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product, with a period of performance through August 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2YZDelivery Order
This delivery order, awarded on August 25, 2025, authorizes AmerisourceBergen Drug Corp to supply 30 tablets of Ayvakit 25 mg under a firm fixed-price arrangement with a ceiling value of $24,368.92. The contract is performed at the company's corporate office in Conshohocken, Pennsylvania, and must be completed by September 16, 2025. The Defense Logistics Agency, under the Department of Defense, issued this non-competitive delivery order as a child contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. This prime indefinite delivery vehicle serves as the pharmaceutical support mechanism enabling AmerisourceBergen to supply a comprehensive range of medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position as a federal medical procurement vendor for Defense Health Agency and other government healthcare systems. The company's extensive portfolio of delivery orders under the SPE2DX contract demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This particular delivery order for Ayvakit, a targeted cancer therapy medication, exemplifies the company's role in supporting military healthcare supply chains through competitively-awarded, firm fixed-price delivery arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 8/25/25 |